Company patents

BOLT MEDICAL, INC.

BOLT MEDICAL, INC. demonstrates a clear focus on Medical Diagnostics & Surgery, comprising 94.0% of its portfolio, yet this core area has seen a significant decline of 47.1% so far in 2026. Surprisingly, despite its name, the company is rapidly expanding its patent activity in Drug Delivery Devices, with a 66.7% growth so far in 2026, indicating an emerging strategic pivot beyond traditional medical diagnostics.

Patent Trend by Technology Area

Yearly patent publications since 2023

Product themes

Product-level themes inferred from filings since 2023, with category chips showing where each theme appears. Select a theme to filter the patents below.

67 US filings (since 2023) · 3 categories · 3 themes

Patents

Showing 11-20 of 96

Page 2 of 10
US 12402946 B2GRANTED
A61B18/24

Breakdown of laser pulse energy for breakup of vascular calcium

Filed:2023-06-30Pub:2025-09-02
Applicant:Boston Scientific Scimed, Inc.

A catheter system ( 100 ) for treating a treatment site ( 106 ) within or adjacent to a blood vessel ( 108 ) includes a power source ( 124 ), a light guide ( 122 ) and a plasma target ( 242 ). In various embodiments, the light guide ( 122 ) receives power from the power source ( 124 ). The light guide ( 122 ) has a distal tip ( 244 ), and the light guide ( 122 ) emits light energy ( 243 ) in a direction away from the distal tip ( 244 ). The plasma target ( 242 ) is spaced apart from the distal tip ( 244 ) of the light guide ( 122 ) by a target gap distance ( 245 ). The plasma target ( 242 ) is configured to receive light energy ( 243 ) from the light guide ( 122 ) so that a plasma bubble ( 234 ) is generated at the plasma target ( 242 ). The power source ( 124 ) can be a laser and the light guide ( 122 ) can be an optical fiber. The catheter system ( 100 ) can also an inflatable balloon ( 104 ) that encircles the distal tip ( 244 ) of the light guide ( 122 ). The plasma target ( 242 ) can be positioned within the inflatable balloon ( 104 ). The plasma target ( 242 ) can have a target face ( 1672 ) that receives the light energy ( 243 ) from the light guide ( 122 ). The plasma target ( 242 ) can be formed from one or more of tungsten, tantalum, platinum, molybdenum, niobium, iridium, magnesium oxide, beryllium oxide, tungsten carbide, titanium nitride, titanium carbonitride and titanium carbide.

US 20250235261 A1APPLICATION
A61B18/24

PLASMA CREATION VIA NONAQUEOUS OPTICAL BREAKDOWN OF LASER PULSE ENERGY FOR BREAKUP OF VASCULAR CALCIUM

Filed:2025-04-07Pub:2025-07-24
Applicant:Boston Scientific Scimed, Inc.

A catheter system ( 100 ) for treating a treatment site ( 106 ) within or adjacent to a blood vessel ( 108 ) includes a power source ( 124 ), a light guide ( 122 ) and a plasma target ( 242 ). In various embodiments, the light guide ( 122 ) receives power from the power source ( 124 ). The light guide ( 122 ) has a distal tip ( 244 ), and the light guide ( 122 ) emits light energy ( 243 ) in a direction away from the distal tip ( 244 ). The plasma target ( 242 ) is spaced apart from the distal tip ( 244 ) of the light guide ( 122 ) by a target gap distance ( 245 ). The plasma target ( 242 ) is configured to receive light energy ( 243 ) from the light guide ( 122 ) so that a plasma bubble ( 234 ) is generated at the plasma target ( 242 ). The power source ( 124 ) can be a laser and the light guide ( 122 ) can be an optical fiber. The catheter system ( 100 ) can also an inflatable balloon ( 104 ) that encircles the distal tip ( 244 ) of the light guide ( 122 ). The plasma target ( 242 ) can be positioned within the inflatable balloon ( 104 ). The plasma target ( 242 ) can have a target face ( 1672 ) that receives the light energy ( 243 ) from the light guide ( 122 ). The plasma target ( 242 ) can be formed from one or more of tungsten, tantalum, platinum, molybdenum, niobium, iridium, magnesium oxide, beryllium oxide, tungsten carbide, titanium nitride, titanium carbonitride and titanium carbide.